Implementation of the New ESC/IC-OS Cardio-Oncology Guidelines in Clinical Practice

Dr Alexander Lyon is a leading London-based consultant cardiologist, specialising in the field of heart failure, cardiomyopathy, cardio-oncology and takotsubo syndrome. He is highly experienced, and is well-versed in all aspects of cardiology. Along with his private clinics at Royal Brompton Hospital and in central London, he is also senior lecturer for the National Heart and Lung Institute at Imperial College London.

Dr Lyon graduated with a first class degree from Oxford University, and gained experience doing post-graduate training in London and Sydney before setting up private practice in London. His clinical interests are in the field of heart failure, chemotherapy cardiomyopathy and Takotsubo cardiomyopathy, and he is the theme leader for heart failure research in the NIHR-funded Biomedical Research Unit at the Royal Brompton Hospital.

Prof Teresa López Fernández is a clinical investigator and consultant cardiologist at La Paz University Hospital in Madrid, ES. She specialises in cardiac imaging (she is board certified in advanced and transesophageal echocardiography by the European Society of Cardiology (ESC)) and cardio-oncology (she is board certified by the International Cardio-Oncology Society), and currently coordinates the cardio-oncology team at La Paz University Hospital. She is the founder and chair of the Spanish Cardio-Oncology Working Group at the Spanish Society of Cardiology (SEC) and the Secretary of the ESC Council of Cardio-Oncology.

Prof Larissa Nekhlyudov is Professor of Medicine at Harvard Medical School, Boston, US and is a practicing primary care physician at the Brigham & Women's Hospital in Boston, US. She is also Clinical Director, Internal Medicine for Cancer Survivors at the Dana-Farber Cancer Institute where she offers clinical care for long term survivors of childhood and adult cancers. Prof Nekhlyudov is particularly interested in improving the care of cancer survivors and the interplay between primary and oncology care. Her publications (including journal articles, book chapters and two books) as well as her broad-ranging educational programs have promoted global awareness among health care providers about the ongoing needs of cancer patients across the care continuum.  Prof Nekhlyudov has been at the forefront of the field of cancer survivorship, nationally and internationally, by leading and participating in the development of policies, clinical guidelines, educational programs, and research. 

Prof Daniel Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.

He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy. 

He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.

Prof Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US. He is the Chief of Staff at the Abramson Cancer Center.

He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.

Dr Susan F Dent is a medical oncologist and professor of medicine at the Duke University School of Medicine, Durham, US. 

Dr. Dent completed her medical education at McMaster University Medical School in Hamilton, Canada. Following this, she undertook residency training in internal medicine and medical oncology at the Ottawa Hospital, University of Ottawa, Ontario, Canada. Her commitment to advancing medical knowledge led her to a postgraduate research fellowship in clinical trials at the Canadian Cancer Trials Group (CCTG) in Kingston, Ontario. Subsequently, she became a staff medical oncologist at the Northwestern Ontario Cancer Center in Thunder Bay.

Dr Dent is the associate director of breast cancer clinical research and co-director of the cardio-oncology program at Duke Health. In 2001, she specialised in the treatment of breast cancer. In 2008, Dr Dent, working with her cardiology colleagues, established a multidisciplinary cardio-oncology clinic in Ottawa; the first of its kind in Canada. In 2011, she founded the Canadian Cardiac Oncology Network (CCON), a not-for-profit organisation devoted to optimisation of cancer care for patients without compromising cardiovascular health.